Results 241 to 250 of about 12,028 (292)

Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi   +2 more
wiley   +1 more source

Advancing fetal autopsy in cases of maceration: Underwater dissection technique and its forensic relevance

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Fetal autopsy remains essential for determining the cause of intrauterine death and for supporting clinical, genetic, and forensic evaluations. However, in cases of advanced maceration, autolysis severely compromises tissue integrity, often preventing adequate identification of anatomical structures and limiting the diagnostic and medico‐legal
Francesca Buffelli   +4 more
wiley   +1 more source

Narrative review of the ethics of artificial intelligence: are we ready for artificial intelligence in surgery? [PDF]

open access: yesJ Thorac Dis
Yu E   +7 more
europepmc   +1 more source

Identification of a PORCN c.1093C>T (p.Arg365Trp) Variant in a 12-Year-Old Girl With Goltz-Gorlin Syndrome. [PDF]

open access: yesClin Case Rep
Bolzon A   +5 more
europepmc   +1 more source

A Narrative Review of Evolving Techniques in Nonsurgical Rhinoplasty: Risk Profile and Clinical Outcomes of Fillers. [PDF]

open access: yesCureus
Torres Céspedes SC   +8 more
europepmc   +1 more source

Reducing unnecessary preoperative testing in Day Surgery: a Choosing Wisely-based quality improvement study. [PDF]

open access: yesJ Anesth Analg Crit Care
Tessitore L   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy